Journal of Inclusion Phenomena and Macrocyclic Chemistry
2
3
4
5
6
7
8
9
.
.
.
.
.
.
.
.
Ji, H.K., Kismali, G., Gupta, S.C.: Natural products for the pre-
vention and treatment of chronic inꢁammatory diseases: inte-
grating traditional medicine into modern chronic diseases care.
Evid. Based Complement. Altern. Med. 2018, 1–2 (2018)
Gorgani, L., Mohammadi, M., Najafpour, G.D., Nikzad, M.:
Piperine—the bioactive compound of black pepper: from isola-
tion to medicinal formulations. Compr. Rev. Food Sci. Food Saf.
18. Kang, E.J., Baek, Y.M., Hahm, E., Lee, S.H., Pham, X.H., Noh,
M.S., Kim, D.E., Jun, B.H.: Functionalized β-cyclodextrin
immobilized on Ag-embedded silica nanoparticles as a drug
carrier. Int. J. Mol. Sci. 20, 315 (2019)
19. Deng, S., Liu, H., Qi, C., Yang, A., Li, Z.: Study on prepara-
tion and inclusion behavior of inclusion complexes between
β-cyclodextrin derivatives with benzophenone. J. Incl. Phenom.
Macrocycl. Chem. 90, 1–9 (2018)
1
6, 124–140 (2016)
Hjr, H., Bartels-Velthuis, A.A., Vollbehr, N.K., Bruggeman,
R., Knegtering, H., Jtvm, D.J.: Natural medicines for psychotic
disorders: a systematic review. J. Nervous Mental Dis. 206, 81
20. Kfoury, M., Landy, D., Fourmentin, S.: Characterization of
cyclodextrin/volatile inclusion complexes: a review. Molecules
23, 1204 (2018)
(
2018)
21. Qiu, N., Cheng, X., Wang, G., Wang, W., Wen, J., Zhang, Y.,
Song, H., Ma, L., Wei, Y., Peng, A.: Inclusion complex of bar-
bigerone with hydroxypropyl-β-cyclodextrin: preparation and
in vitro evaluation. Carbohydr. Polym. 101, 623–630 (2014)
22. Yildiz, Z.I., Celebioglu, A., Uyar, T.: Polymer-free electrospun
nanoꢀbers from sulfobutyl ether 7-beta-cyclodextrin (SBE 7-β-
CD) inclusion complex with sulꢀsoxazole: fast-dissolving and
enhanced water-solubility of sulꢀsoxazole. Int. J. Pharm. 531,
550–558 (2017)
Bhardwaj, R.K., Hartmut, G., Laurent, B., Ulrich, K., Gupta,
S.K., Fromm, M.F.: Piperine, a major constituent of black pep-
per, inhibits human p-glycoprotein and CYP3A4. J. Pharmacol.
Exp. Ther. 302, 645–650 (2002)
Lee, S.H., Kim, H.Y., Back, S.Y., Han, H.K.: Piperine-mediated
drug interactions and formulation strategy for piperine: recent
advances and future perspectives. Expert Opin. Drug Metab.
Toxicol. 14, 43–57 (2018)
Wang-Sheng, C., Jie, A., Jian-Jun, L., Lan, H., Zeng-Bao, X.,
Chang-Qing, L.: Piperine attenuates lipopolysaccharide (LPS)-
induced inꢁammatory responses in BV2 microglia. Int. Immu-
nopharmacol. 42, 44–48 (2017)
23. Yan, C., Liang, N., Li, Q., Yan, P., Sun, S.: Biotin and arginine
modiꢀed hydroxypropyl-β-cyclodextrin nanoparticles as novel
drug delivery systems for paclitaxel. Carbohydr. Polym. 216,
129–139 (2019)
Ying, X., Yu, K., Chen, X., Chen, H., Hong, J., Cheng, S., Peng,
L.: Piperine inhibits LPS induced expression of inꢁammatory
mediators in RAW 264.7 cells. Cell. Immunol. 285, 49–54
24. Guo, L., Cao, X., Yang, S., Wang, X., Wen, Y., Zhang, F., Chen,
H., Wang, L.: Characterization, solubility and antibacterial
activity of inclusion complex of questin with hydroxypropyl-β-
cyclodextrin. 3 Biotech 9, 123 (2019)
(
2013)
Hegeto, L.A., Caleꢂ-Ferracioli, K.R., Nakamura-Vasconcelos,
S.S., Almeida, A.L.D., Baldin, V.P., Nakamura, C.V., Siqueira,
V.L.D., Scodro, R.B.L., Cardoso, R.F.: In vitro combinatory
activity of piperine and anti-tuberculosis drugs in mycobacte-
rium tuberculosis. Tuberculosis 111, 35 (2018)
25. Jain, A.S., Date, A.A., Pissurlenkar, R.R.S., Coutinho,
E.C., Nagarsenker, M.S.: Sulfobutyl Ether7β-Cyclodextrin
(SBE7β-CD) carbamazepine complex: preparation, charac-
terization, molecular modeling, and evaluation of in vivo anti-
epileptic activity. AAPS PharmSciTech 12, 1163–1175 (2011)
26. Lv, P., Liu, M., Liao, R., Zhao, Y., Liao, X., Gao, C., Yang, B.:
Host–guest inclusion system of rhein with polyamine-modiꢀed
β-cyclodextrins: characterization and cytotoxicity. Pharm. Dev.
Technol. 22, 669–677 (2017)
1
1
0. Alshehri, S., Haq, N., Shakeel, F.: Solubility, molecular inter-
actions and mixing thermodynamic properties of piperine in
various pure solvents at diꢃerent temperatures. J. Mol. Liq. 250,
6
3–70 (2018)
1. Shoba, G., Joy, D., Joseph, T., Majeed, M., Rajendran, R.,
Srinivas, P.S.: Inꢁuence of piperine on the pharmacokinetics
of curcumin in animals and human volunteers. Planta Med. 64,
27. Jae, C., Eunil, H., Kyeonghui, P., Daham, J., Won-Yeop, R.,
Jaehi, K., Dae, J., Yoon-Sik, L., Sung, J., Hyun, C.: SERS-based
ꢁavonoid detection using ethylenediamine-β-cyclodextrin as a
capturing ligand. Nanomaterials 7, 8 (2017)
3
53–356 (1998)
1
1
2. Zafar, F., Jahan, N., Bhatti, H.: Increased oral bioavailability
of piperine from an optimized Piper nigrum nanosuspension.
Planta Med. 85, 249–257 (2019)
28. Gu, X., Mathias, E.V., Nguyen, K.T.H., Yong, B.: Structural
characterization and diꢃusional analysis of the inclusion com-
plexes of ꢁuoroadamantane with β-cyclodextrin and its deriva-
tives studied via 1 H, 13 C and 19 F NMR spectroscopy. J. Incl.
Phenom. Macrocycl. Chem. 76, 427–441 (2013)
3. Zidan, M.F., Ibrahim, H.M., Afouna, M.I., Ibrahim, E.A.:
In vitro and in vivo evaluation of cyclodextrin-based nano-
sponges for enhancing oral bioavailability of atorvastatin cal-
cium. Drug Dev. Commun. 44, 1243–1253 (2018)
29. Zhi, S., Qi, Q., Liao, X., Bo, Y.: Host–guest inclusion system of
glycyrrhetic acid with polyamine-β-cyclodextrin: preparation,
characterization, and anticancer activity. J. Mol. Struct. 1149,
155–161 (2017)
1
1
4. Dong, Q., Yuan, E., Huang, M., Zheng, J.: Increased solubil-
ity and taste masking of a ternary system of neodiosmin with
β-cyclodextrin and lysine. Starch-Stärke 69, 1600322 (2017)
5. Yang, L.J., Chang, Q., Zhou, S.Y., Yang, Y.H., Xia, F.T., Wen,
C., Li, M., Yang, X.D.: Host–guest interaction between brazilin
and hydroxypropyl-β-cyclodextrin: preparation, inclusion mode,
molecular modelling and characterization. Starch-Stärke 150,
30. Shanmuga Priya, A., Balakrishnan, S.B., Veerakanellore, G.B.,
Stalin, T.: In-vitro dissolution rate and molecular docking stud-
ies of cabergoline drug with β-cyclodextrin. J. Mol. Struct.
1160, 1–8 (2018)
31. Das, S.K., Kahali, N., Bose, A., Khanam, J.: Physicochemical
characterization and in vitro dissolution performance of ibupro-
fen-Captisol? (sulfobutylether sodium salt of β-CD) inclusion
complexes. J. Mol. Liquids 261, 239–249 (2018)
1
93–201 (2018)
1
1
6. Huang, Q., Jiang, L., Liang, W., Gui, J., Xu, D., Wu, W., Nakai,
Y., Nishijima, M., Fukuhara, G., Mori, T.: Inherently chiral azo-
nia[6]helicene-modiꢀed β-cyclodextrin: synthesis, characteri-
zation, and chirality sensing of underivatized amino acids in
water. J. Org. Chem. 81, 3430–3434 (2016)
32. Yang, L.J., Wang, S.H., Zhou, S.Y., Zhao, F., Yang, X.D.:
Supramolecular system of podophyllotoxin and hydroxypropyl-
β-cyclodextrin: characterization, inclusion mode, docking cal-
culation, solubilization, stability and cytotoxic activity. Mater.
Sci. Eng. C 76, 1136 (2017)
7. Qi, C., Liu, H., Deng, S., Yang, A.H., Li, Z.: A modeling study
by response surface methodology (RSM) on Th(IV) adsorption
optimization using a sulfated β-cyclodextrin inclusion complex.
Res. Chem. Intermed. 44, 1–23 (2018)
33. Siva Kumar, K., Parinamachivayam, G., Muralikrishnan, M.,
Chakravarty, S., Bharathi, A.: Preparation, characterization and
1
3